Plain-English analysis of the developments shaping the U.S. public markets — from SEC and Nasdaq rule changes to the mechanics of going public — for founders, boards, and investors.
Nasdaq and NYSE American are converging on a $5 million floor — enforced fast, with the cure period stripped out. Here is the pattern every small-cap board should be reading — and why a reverse split still won’t save you.
Read the article →What small- and micro-cap boards need to understand about the new market-value continued-listing standard — before it forces the issue.
Read the article →There are three principal ways to take a company public in the United States. Here is how I help clients choose — and the honest trade-offs of each.
Read the article →A proposed overhaul of the registered-offering and reporting rules could meaningfully lower the cost of going — and staying — public. Here is the practical read for smaller issuers.
Read the article →Most engagements begin with a short introductory call. We'll listen to where you are, sketch the likely path, and be candid about the benefits, the trade-offs, and what it takes.
Get in touch